Full Text
Full text is available in PDF
Ulcerative Colitis Remission after Renal Transplantation: Two Case Reports
1Department of Nephrology, Baqiyatallah University of Medical Sciences, rostami@inu.ir, IR-Iran
2Baqiyatallah Hospital Tehran Hepatitis Center, IR-Iran
*Corresponding Author: Department of Nephrology, Baqiyatallah University of Medical Sciences, rostami@inu.ir, IR-Iran. Email: rostami@inu.ir
Published online:Jan 31, 2010
Article type:Case Report
Received:Apr 20, 2009
Accepted:May 10, 2009
Abstract
The combination of ulcerative colitis (UC) and end stage renal disease (ESRD) is uncommon. Immunosuppressive drugs that are used after kidney transplantation are considered as effective therapeutic alternatives for UC. We report two renal transplant recipients with long term refractory UC prior to kidney transplantation and confirmed by histological examination, cured following transplantation. Clinical remission occurred immediately after kidney transplantation, and they had no symptoms of UC during 3 and 8 years of follow up periods. Their immunosuppression regimens were cyclosporine, mycophenolate mofetil / azathioprine and prednisone.
Conclusion: Kidney transplantation with immunosuppression leads to clinical remission in patients with the inflammatory bowel diseases and ESRD.
Highlights
How to Cite:Rostami Z, Alavian S, Einollahi B. Ulcerative Colitis Remission after Renal Transplantation: Two Case Reports. Nephro-Urol Mon. 2010;2(1):. doi:
Copyright
© 2010, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
1
Mar
2012
Efficacy of Anti-Interleukin-2 Receptor Antibody (Daclizumab) in Reducing the Incidence of Acute Rejection After Renal Transplantation
Hossein Saghafi,
Khosrow Rahbar,
Ali Haghighi,
Mohammad Qoreishi,
Farshad Safdari
Saghafi H, Rahbar K, Haghighi A, Qoreishi M, Safdari F. Efficacy of Anti-Interleukin-2 Receptor Antibody (Daclizumab) in Reducing the Incidence of Acute Rejection After Renal Transplantation. Nephro-Urol Mon. 2012;4(2):475-477. doi: https://doi.org/10.5812/numonthly.1806
30
Mar
2024
De Novo Inflammatory Bowel Disease after Liver Transplantation: Eleven Years' Experience in Shiraz, Iran
Yousef Paridar,
Aziz Kassani
Paridar Y, Kassani A. De Novo Inflammatory Bowel Disease after Liver Transplantation: Eleven Years' Experience in Shiraz, Iran. J Adv Immunopharmacol. 2024;4(1):e143623. doi: https://doi.org/10.5812/jai-143623
13
Jan
2014
Infective Endocarditis After Renal Transplantation
Maryam Moshkani Farahani,
Zohreh Rostami,
Behzad Einollahi,
Arezoo Khosravi,
Eghlim Nemati,
Mahboob Lessan Pezeshki
,et al.Moshkani Farahani M, Rostami Z, Einollahi B, Khosravi A, Nemati E, et al. Infective Endocarditis After Renal Transplantation. Nephro-Urol Mon. 2014;6(1):e12326. doi: https://doi.org/10.5812/numonthly.12326
30
Jun
2005
Renal Cell Carcinoma in Transplanted Kidney
Minoo Naroiinejad,
R Salouti
Naroiinejad M, Salouti R. Renal Cell Carcinoma in Transplanted Kidney. I J Radiol. 2005;2(3&4):e79129. doi:
30
Mar
2013
Role of Renal Re-transplantation in ESRD Patients
Alireza Ghadian,
Mohammad Hossein Nourbala
Ghadian A, Nourbala MH. Role of Renal Re-transplantation in ESRD Patients. Nephro-Urol Mon. 2013;5(2):721-2. doi: https://doi.org/10.5812/numonthly.11155
More by these authors
Cited by
- Scopus by DOI: 0
Last Update: 4 days ago
- Scopus by Title: 0
Last Update: 4 days ago
- Scopus by Title (Ref): 0
Last Update: 4 days ago
- CrossRef: 0
Last Update: 4 days ago
- OpenAlex: 0
Last Update: 2 days ago
- OpenCitations: 0
Last Update: 1 day ago
Comments
Number of Comments:0Indexed in
